CORTESE, ROSA
 Distribuzione geografica
Continente #
EU - Europa 1.925
AS - Asia 1.322
NA - Nord America 1.315
SA - Sud America 372
AF - Africa 27
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.964
Nazione #
US - Stati Uniti d'America 1.282
SG - Singapore 505
RU - Federazione Russa 503
IT - Italia 485
CN - Cina 327
BR - Brasile 324
IE - Irlanda 323
HK - Hong Kong 149
GB - Regno Unito 135
SE - Svezia 119
VN - Vietnam 94
KR - Corea 92
FR - Francia 77
DE - Germania 75
FI - Finlandia 57
ES - Italia 54
IN - India 50
NL - Olanda 32
CA - Canada 16
TR - Turchia 15
AR - Argentina 14
BD - Bangladesh 14
IR - Iran 14
ID - Indonesia 12
PL - Polonia 12
AT - Austria 11
ZA - Sudafrica 11
UA - Ucraina 10
IQ - Iraq 9
MX - Messico 9
CH - Svizzera 8
CL - Cile 7
CO - Colombia 7
EC - Ecuador 7
JP - Giappone 7
HU - Ungheria 6
PK - Pakistan 6
BE - Belgio 5
CI - Costa d'Avorio 5
PY - Paraguay 5
SA - Arabia Saudita 5
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
JO - Giordania 3
MA - Marocco 3
MN - Mongolia 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
OM - Oman 2
PH - Filippine 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.964
Città #
Dallas 325
Dublin 299
Singapore 268
Santa Clara 220
Hong Kong 146
Moscow 135
Hefei 122
Ashburn 97
Southend 95
Seoul 92
Siena 84
Beijing 83
Milan 61
Chandler 49
Los Angeles 44
Málaga 44
Ho Chi Minh City 33
Helsinki 31
Munich 31
Princeton 31
São Paulo 29
Rome 27
Fairfield 23
Florence 23
Bengaluru 21
Buffalo 18
Hanoi 16
New York 16
Pisa 16
Lappeenranta 15
Redondo Beach 14
Cambridge 13
Nuremberg 13
San Francisco 13
Boston 12
Houston 12
Sarzana 12
Seattle 12
Chicago 11
Wilmington 11
Belo Horizonte 10
Livorno 10
Lucca 10
Salvador 10
Woodbridge 10
London 9
Reggio Emilia 9
Rio de Janeiro 9
Carlentini 8
Fremont 8
Montreal 8
Naples 8
Phoenix 8
Turin 8
Turku 8
Warsaw 8
Chennai 7
Dong Ket 7
Porto Alegre 7
Tokyo 7
Amsterdam 6
Bari 6
Brooklyn 6
Campinas 6
Frankfurt am Main 6
Orem 6
Sacramento 6
Shanghai 6
Tehran 6
Abidjan 5
Atlanta 5
Baghdad 5
Boardman 5
Brasília 5
Brussels 5
Council Bluffs 5
Falkenstein 5
Gyomro 5
Mexico City 5
Monsummano Terme 5
San Diego 5
Vicopisano 5
Americana 4
Columbus 4
Denver 4
Des Moines 4
Dhaka 4
Haiphong 4
Hải Dương 4
Jacksonville 4
Johannesburg 4
Manchester 4
Messina 4
Nairobi 4
New Delhi 4
Pescara 4
Pistoia 4
Salt Lake City 4
São José do Rio Preto 4
Tashkent 4
Totale 2.977
Nome #
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 267
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 170
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 166
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 163
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 145
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 134
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 121
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 116
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 114
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging 106
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years 105
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis 105
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy 105
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique 103
Uveitis: A snapshot in the MOG antibody spectrum 102
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 102
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 101
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 100
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 99
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 98
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 97
Gender Inequities in the Multiple Sclerosis Community: A Call for Action 96
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation 95
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD 95
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 94
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis 92
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio 92
Editorial: Cognition in Multiple Sclerosis 91
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 90
Advances in brain imaging in multiple sclerosis 90
Fatigue in multiple sclerosis: The role of thalamus 87
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging – Yes 87
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique 87
Evaluation of cervical spinal cord atrophy using a modified SIENA approach 84
Vessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation 84
Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (npj Digital Medicine, (2019), 2, 1, (49), 10.1038/s41746-019-0127-8) 84
High-dimensional detection of imaging response to treatment in multiple sclerosis 83
Magnetic resonance imaging evidence supporting the efficacy of cladribine tablets in the treatment of relapsing-remitting multiple sclerosis 81
Structural and functional connectivity substrates of cognitive impairment in multiple sclerosis 81
MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease 79
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis 79
Primary progressive multiple sclerosis presenting under the age of 18 years: Fact or fiction? 78
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis 77
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study 72
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know? 71
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 71
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression 66
Amyotrophic lateral sclerosis: A new missense mutation in the SOD1 gene 56
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 54
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 50
The role of imaging in Hirayama disease 27
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 25
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 24
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP) 24
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 23
Hirayama disease: the importance of an early diagnosis 22
Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal 21
Totale 5.131
Categoria #
all - tutte 21.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 6 3 11 10 12 7 9
2021/2022227 4 1 3 2 3 6 2 1 83 9 52 61
2022/2023528 25 36 78 47 20 86 71 41 47 46 14 17
2023/2024453 12 14 37 18 10 109 175 13 6 12 5 42
2024/20251.653 47 67 145 95 211 83 83 107 145 95 171 404
2025/20262.094 303 460 352 410 549 20 0 0 0 0 0 0
Totale 5.131